Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia
Atorvastatin reduced hs-CRP levels in patients with stable CAD
Atorvastatin: a review of its pharmacological properties and use in familial hypercholesterolemia
Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-alpha
Atorvastatin stimulates neuroblastoma cells to induce neurite outgrowth by increasing cellular prion protein expression
Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy
Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease
Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial
Atorvastatin 10 mg plus ezetimibe 10 mg compared with atorvastatin 20 mg: Impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease
Atorvastatin prevents angiotensin II-induced high permeability of human arterial endothelial cell monolayers via ROCK signaling pathway
Atorvastatin for high-risk statin-naive patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial
Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices
Atorvastatin-induced necrotizing autoimmune myositis An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype
Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile
Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice
Atorvastatin alleviates renal ischemia-reperfusion injury in rats by promoting M1-M2 transition
Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4
Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque
Atorvastatin Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Swine After Coronary Microembolization
Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro
Atorvastatin Attenuates Ischemia/Reperfusion-Induced Hippocampal Neurons Injury Via Akt-nNOS-JNK Signaling Pathway
Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein beta
Atorvastatin as a promising anticryptococcal agent
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study
Atorvastatin inhibits proliferation and calcification of rat heart valve interstitial cells via activating the mTOR signaling pathway
Atorvastatin treatment is associated with increased BDNF level and improved functional recovery after atherothrombotic stroke
Atorvastatin prolongs the lifespan of radiation-induced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect
Atorvastatin-induced osteoclast inhibition reduces orthodontic relapse
Atorvastatin from target screening attenuates endothelial cell tube formation and migration by regulating urokinase receptor-related signaling pathway and F/G actin
Atorvastatin Treatment and Carotid Plaque Morphology in First-ever Atherosclerotic Transient Ischemic Attack/Stroke: A Case-Control Study
Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor gamma activation
Atorvastatin might inhibit insulin resistance induced by insulin through the triglyceride-lowering role of Apolipoprotein AV
Atorvastatin protects myocardium against ischemia-reperfusion arrhythmia by increasing Connexin 43 expression: A rat model
Atorvastatin Treatment for Atrial Fibrillation Reduces Serum High-Sensitivity C-Reactive Protein Levels
Atorvastatin induces autophagic cell death in prostate cancer cells in vitro
Atorvastatin improves cardiac function of rats with chronic cardiac failure via inhibiting Rac1/P47(phox)/P67(phox)-mediated ROS release
Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis
Atorvastatin up-regulates TRIB3 independent of ATF4-CHOP pathway in atherosclerotic patients
Atorvastatin counteracts high glucose-induced Kruppel-like factor 2 suppression in human umbilical vein endothelial cells
Atorvastatin treatment improves effects of implanted mesenchymal stem cells: meta-analysis of animal models with acute myocardial infarction
Atorvastatin attenuates inflammation and oxidative stress induced by ischemia/reperfusion in rat heart via the Nrf2 transcription factor
Atorvastatin as adjunctive therapy for chronic plaque type psoriasis versus betamethasone valerate alone: A randomized, double-blind, placebo-controlled trial
Atorvastatin-induced dermatomyositis
Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression
Atorvastatin inhibits vascular smooth muscle cell phenotype transformation in cerebral hemorrhage rats by down regulating KLF-5
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling
Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome
Atorvastatin alleviates cardiomyocyte apoptosis by suppressing TRB3 induced by acute myocardial infarction and hypoxia
Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers
Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat beta-Cells. Direct Effect of Oxidative Stress
Atorvastatin increases Fads1, Fads2 and Elovl5 gene expression via the geranylgeranyl pyrophosphate-dependent
Atorvastatin alleviates iodinated contrast media-induced cytotoxicity in human proximal renal tubular epithelial cells
Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice
Atorvastatin and lovastatin, but not pravastatin, increased cellular complex formation between PCSK9 and the LDL receptor in human hepatocyte-like C3A cells
Atorvastatin Protects from A beta(1-40)-Induced Cell Damage and Depressive-Like Behavior via ProBDNF Cleavage
Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1 alpha inhibition
Atorvastatin has a protective effect in a mouse model of bronchial asthma through regulating tissue transglutaminase and triggering receptor expressed on myeloid cells-1 expression
Atorvastatin/trimetazidine combination therapy in patients with chronic cardiac failure
Atorvastatin can ameliorate left atrial stunning induced by radiofrequency ablation for atrial fibrillation
Atorvastatin enhances endothelial cell function in posttransplant poor graft function
Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism
Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3 beta-PP2Ac-NF-kappa B Signaling Axis
Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills
Atorvastatin at Reperfusion Reduces Myocardial Infarct Size in Mice by Activating eNOS in Bone Marrow-Derived Cells
Atorvastatin preserves the integrity of endothelial adherens junctions by inhibiting vascular endothelial cadherin tyrosine phosphorylation
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease
Atorvastatin Metabolite Measurements as a Diagnostic Tool for Statin-Induced Myopathy
Atorvastatin and clopidogrel interfere with photosensitization in vitro
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study
Atorvastatin reduces beta-Adrenergic dysfunction in rats with diabetic cardiomyopathy
Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases
Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels
Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress
Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study
Atorvastatin attenuates oxidative stress in patients with chronic kidney disease